logo image
search icon
Global Fragment-Based Drug Discovery Market

Fragment-Based Drug Discovery Market Size, Share & Trends Analysis Report By Technique (X-ray Crystallography, Nuclear Magnetic Resonance, Surface Plasmon Resonance. and Other Screening Techniques), By Service, By End Users, Region And Segment Forecasts, 2023-2031.

Report ID : 1175 | Published : 2024-03-15 | Pages: 180 | Format: PDF/EXCEL

The Fragment-Based Drug Discovery Market is expected to grow at a 11.0 % CAGR during the forecast period for 2023-2031.

Fragment-Based Drug Discovery Market

Fragment-based Drug Discovery is being used to find similar compounds like lead in drug discovery process, which is based on identification of chemical fragments, this chemical fragment may be biological target or on combining them produce a lead molecule.

Increasing novel complex medical problems creating the demand for newer fragment-based drug discovery. Moreover, as a result of increasing demand, the market for fragment-based drug discovery dominating the biopharmaceutical companies. The upsurge in technology for biophysical fragment screening is become key drivers of global fragment-based drug discovery market. Moreover, these systems providing promising access in creating chemical with similar properties like lead.  Additionally, the fragment-based drug discovery systems found to be useful in marking out chemical series molecule from multiple targets, also pharmaceutical companies have increases the spending on research and development expected to create the lucrative growth in market near the future.

Market Segmentation

The Global Fragment-based Drug Discovery market is segmented on the basis of technique, service, end users and region. Based on the base technique, the market is divided into x-ray crystallography, nuclear magnetic resonance, surface plasmon resonance and other screening techniques. On the basis of service, the market is segmented into library screening, fragment screening and fragment optimization. Based on the end users, the market is divided into hospitals, industry players and non-industry players. Based on region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among that Europe held the largest share of the market, followed by America and Asia Pacific. On the other hand, North America is expected to dominate the market during the analysis of forecast period.

Competitive Landscape

Some of The Key Players in The Fragment-Based Drug Discovery Market:

  • 2bind
  • Charles River Laboratories
  • ChemAxon
  • ComInnex
  • ChemDiv
  • Creative Biolabs
  • Creative Biostructure
  • CRELUX
  • Domainex
  • Evotec
  • Red Glead Discovery
  • SARomics Biostructures
  • Shanghai ChemPartner
  • Sygnature Discovery
  • Vernalis
  • Other Prominent Players

The Fragment-Based Drug Discovery Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 11.0 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Technique, By Service, By End Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

2bind, Charles River Laboratories, ChemAxon, ComInnex, ChemDiv, Creative Biolabs, Creative Biostructure, CRELUX, Domainex, Evotec, Red Glead Discovery, SARomics Biostructures, Shanghai ChemPartner, Sygnature Discovery, and Vernalis among others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Fragment-based Drug Discovery Market Snapshot

Chapter 4. Global Fragment-based Drug Discovery Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Technology Advancement in Fragment-based Drug Discovery Market

4.8. Key Trends in the Market

Chapter 5. Market Segmentation 1: Type of Technique Estimates & Trend Analysis

5.1. Type of Technique & Market Share, 2020 & 2028

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Technique:

5.2.1. X-ray Crystallography

5.2.2. Nuclear Magnetic Resonance

5.2.3. Surface Plasmon Resonance

5.2.4. Other Screening Techniques

Chapter 6. Market Segmentation 1: Type of Service Estimates & Trend Analysis

6.1. Type of Service & Market Share, 2020 & 2028

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type of Service:

6.2.1. Library Screening

6.2.2. Fragment Screening

6.2.3. Fragment Optimization

Chapter 7. Fragment-based Drug Discovery Market Segmentation 2: End-Users Estimates & Trend Analysis

7.1. End-Users Analysis & Market Share, 2020 & 2028

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

7.2.1. Industry Players

7.2.2. Non-industry Players

Chapter 8. Fragment-based Drug Discovery Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Technique, 2020-2028

8.1.2. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by Type of Service, 2020-2028

8.1.3. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by End-Users, 2020-2028

8.1.4. North America Fragment-based Drug Discovery Market revenue (US$ Million) estimates and forecasts by country, 2020-2028

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028

8.2.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028

8.2.3. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028

8.2.4. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, 2020-2028

8.3.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028

8.3.3. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, 2020-2028

8.3.4. Asia Pacific Fragment-based Drug Discovery Market revenue (US$ Million) by country, 2020-2028

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million)

8.4.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028

8.4.3. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by End-Users, (US$ Million)

8.4.4. Latin America Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Technique, (US$ Million) 2020-2028

8.5.2. Europe Fragment-based Drug Discovery Market revenue (US$ Million) by Type of Service, 2020-2028

8.5.3. MEA revenue Fragment-based Drug Discovery Market revenue (US$ Million) by country, (US$ Million) 2020-2028

8.5.3.1. South Africa

8.5.3.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. 2bind

9.2.2. Charles River Laboratories

9.2.3. ChemAxon

9.2.4. ComInnex

9.2.5. ChemDiv

9.2.6. Creative Biolabs

9.2.7. Creative Biostructure

9.2.8. CRELUX

9.2.9. Domainex

9.2.10. Evotec

9.2.11. Red Glead Discovery

9.2.12. SARomics Biostructures

9.2.13. Shanghai ChemPartner

9.2.14. Sygnature Discovery

9.2.15. Vernalis

9.2.16. Other Prominent Player

Global Fragment-based Drug Discovery Market Segmentation:

Global Fragment-based Drug Discovery Market Revenue (US$ Mn) by Technique

  • X-ray Crystallography
  • Nuclear Magnetic Resonance
  • Surface Plasmon Resonance
  • Biolayer Interferometry
  • DSF Assay
  • Mass Spectrometry (MS) 
  • Capillary Electrophoresis (CE)
  • Fluorescence Polarization (FP)
  • Other Screening Techniques

 

Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Service

  • Library Screening
  • Fragment Screening
  • Fragment Optimization

Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on End Users

  • Hospitals
  • Industry Players
  • Non-industry Players

Global Fragment-based Drug Discovery Market Revenue (US$ Mn) Based on Region

Europe Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country

  • U.S.
  • Canada

Asia Pacific Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Fragment-based Drug Discovery Market Revenue (US$ Mn) by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the Fragment-Based Drug Discovery Market Growth?

2bind, Charles River Laboratories, ChemAxon, ComInnex, ChemDiv, Creative Biolabs, Creative Biostructure, CRELUX, Domainex, Evotec, Red Glead Discovery

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach